Study finds fourfold increase in risk of overt hypothyroidism after diagnosis of gestational subclinical hypothyroidism

FHS
August 2, 2024
10:26 pm

A new study has shown that subclinical hypothyroidism diagnosed before 21 weeks of pregnancy is associated with more than fourfold higher rates of overt hypothyroidism or thyroid replacement therapy within 5 years of delivery.

Nurse Shortage, Burnout Top Concerns for Healthcare Workers: AI Seen as Potential Solution

What You Should Know: – A new survey by Carta Healthcare®, a company focused on harnessing the power of clinical data, sheds light on the

March 20, 2024

BIO CEO’s patriotic pivot; Step forward for Lilly’s Alzheimer’s drug; Pfizer’s gene therapy setback; Foresite’s $900M fund

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 16, 2024

Charles River’s CDMO revenue rise; Catalent lays off 300 staffers; Biogen’s idle capacity

Charles River’s overall manufacturing business saw a 9.5% decrease in revenue in the last quarter of 2023 with $191.9 million, versus $212.1 million in the

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.